Leukemia, Lymphoblastic: Clinical Trials

3 trials for Leukemia, Lymphoblastic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Terminated 1

Follow Leukemia, Lymphoblastic: new trials by email Literature Review of Leukemia, Lymphoblastic trials Research Report on Leukemia, Lymphoblastic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ETOILE : A Feasibility Study in Pediatric Patient Education
ETOILE therapeutic education - Leukemia, Lymphoblastic
Not applicableCompletedAssistance Publique - Hôpitaux de Paris102020-07-092021-10-18
The SMART CART Study: Health Information Technology
Education information system, Activity monitor, Interview - Leukemia, Acute, Leukemia, Lymphoblastic
Not applicableCompletedUniversity of Michigan Rogel Cancer Center1482017-12-202024-03-22
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
Methylphenidate, Placebo - ALL, Childhood, Leukemia, Lymphoblastic
Not applicableTerminatedUniversity of Minnesota12010-05-012015-03-27

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Brain Neoplasms (1)  ·  Leukemia (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Leukemia (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)

Interventions

Fitness Trackers (1)  ·  Interviews as Topic (1)  ·  Methylphenidate (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  University of Michigan Rogel Cancer Center (1)  ·  University of Minnesota (1)

Countries

United States (2)  ·  France (1)

Top investigators

Alicia Kunin-Batson, Ph.D. (1)  ·  Sung Won Choi, MD, MS (1)